novel somatic germline mutations intracranial germ cell tumours 
intracranial germ cell tumours igcts group rare heterogeneous brain tumours clinically histologically similar common gonadal gcts igcts show great variation geographical gender distribution histological composition treatment outcomes incidence igcts historically five eightfold greater japan east asian countries western countries1 peak incidence near time puberty2 half tumours located pineal region male to-female incidence ratio approximately -: overall even higher tumours located pineal region3 owing scarcity tumour specimens available research little currently known rare disease report analysis cases next-generation sequencing single nucleotide polymorphism array expression array find kit/ras signalling pathway frequently mutated % igcts including novel recurrent somatic mutations kit downstream mediators kras nras negative regulator cbl novel somatic alterations akt/mtor pathway included copy number gains akt1 locus 14q3233 % patients corresponding upregulation akt1 expression identified loss-of-function mutations bcorl1 transcriptional co-repressor tumour suppressor report significant enrichment novel rare germline variants jmjd1c codes histone demethylase coactivator androgen receptor among japanese igct patients study establishes molecular foundation understanding biology igcts suggests potentially promising therapeutic strategies focusing inhibition kit/ras activation akt1/mtor pathway 
